Evidence map›Paper›PMID 23997379›Full record

ArticleJournal of business ethics : JBE2013

The Limits of Corporate Social Responsibility: Techniques of Neutralization, Stakeholder Management and Political CSR.

Gary Fooks, Anna Gilmore, Jeff Collin, Chris Holden, Kelley Lee

Open access · hybridAbstract read
In one paragraph

Article in Journal of business ethics : JBE, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
35.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 288 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Mobilizing for Health: A Case Study of Kazakhstan's Vaping Ban Advocacy Campaign.International journal of environmental research and public health · 2025
    Article
  6. Article
  7. Bibliometric Analysis of Corporate Social Responsibility and Its Impact on Community Health.International journal of environmental research and public health · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Gary FooksDepartment of Health, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Anna Gilmore
Jeff Collin
Chris Holden
Kelley Lee
Simon Fraser University · CAUniversity of Bath · GBUniversity of Edinburgh · GBUniversity of York · GB

Funding

Tobacco Companies, Global Governance and Public HealthR01CA160695 · NCI · UNIVERSITY OF BATH · PI GILMORE, ANNA B · 2011 to 2013
$1.3M
Medical Research Council MR/K023195/1NCI NIH HHS R01 CA160695
6 · The paper itself

Abstract

Since scholarly interest in corporate social responsibility (CSR) has primarily focused on the synergies between social and economic performance, our understanding of how (and the conditions under which) companies use CSR to produce policy outcomes that work against public welfare has remained comparatively under-developed. In particular, little is known about how corporate decision-makers privately reconcile the conflicts between public and private interests, even though this is likely to be relevant to understanding the limitations of CSR as a means of aligning business activity with the broader public interest. This study addresses this issue using internal tobacco industry documents to explore British-American Tobacco's (BAT) thinking on CSR and its effects on the company's CSR Programme. The article presents a three-stage model of CSR development, based on Sykes and Matza's theory of techniques of neutralization, which links together: how BAT managers made sense of the company's declining political authority in the mid-1990s; how they subsequently justified the use of CSR as a tool of stakeholder management aimed at diffusing the political impact of public health advocates by breaking up political constituencies working towards evidence-based tobacco regulation; and how CSR works ideologically to shape stakeholders' perceptions of the relative merits of competing approaches to tobacco control. Our analysis has three implications for research and practice. First, it underlines the importance of approaching corporate managers' public comments on CSR critically and situating them in their economic, political and historical contexts. Second, it illustrates the importance of focusing on the political aims and effects of CSR. Third, by showing how CSR practices are used to stymie evidence-based government regulation, the article underlines the importance of highlighting and developing matrices to assess the negative social impacts of CSR.

Indexed as

Corporate political activityCorporate social responsibilityPolitical CSRStakeholder managementTechniques of neutralization

Identifiers

PMID23997379
PMCPMC3755635
OpenAlexW2137566630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.